Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berend Jan Bosch

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Antiviral Research|December 4, 2012
Novel polymeric inhibitors of HCoV-NL63Aleksandra Milewska, Justyna Ciejka, Kamil Kaminski, et al.
Journal of Virology|November 3, 2017
Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric InfectionsXiaoli Xiong, M Alejandra Tortorici, Joost Snijder, et al.
Scientific Reports|December 9, 2020
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63Giulietta Saletti, Thomas Gerlach, Janina M Jansen, et al.
Journal of Virology|December 14, 2007
Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion proteinBerend Jan Bosch, John W A Rossen, Willem Bartelink, et al.
Journal of Virology|April 7, 2017
Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing AntibodiesChunhua Li, Wentao Li, Eduardo Lucio de Esesarte, et al.
Viruses|January 21, 2023
Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The NetherlandsReina S Sikkema, Erwin de Bruin, Christian Ramakers, et al.
Virulence|January 8, 2026
The essential role of heparan sulfate in the entry of PDCoV and other porcine coronavirusesNingning Ma, Mengjia Zhang, Ahmed H Ghonaim, et al.
Science Advances|May 7, 2021
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11Juliette Fedry, Daniel L Hurdiss, Chunyan Wang, et al.
One Health Outlook|June 23, 2022
Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasJordi Rodon, Anna Z Mykytyn, Guillermo Cantero, et al.
Emerging Infectious Diseases|November 27, 2014
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997Marcel A Müller, Victor Max Corman, Joerg Jores, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Antiviral Research|December 4, 2012
Novel polymeric inhibitors of HCoV-NL63Aleksandra Milewska, Justyna Ciejka, Kamil Kaminski, et al.
Journal of Virology|November 3, 2017
Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric InfectionsXiaoli Xiong, M Alejandra Tortorici, Joost Snijder, et al.
Scientific Reports|December 9, 2020
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63Giulietta Saletti, Thomas Gerlach, Janina M Jansen, et al.
Journal of Virology|December 14, 2007
Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion proteinBerend Jan Bosch, John W A Rossen, Willem Bartelink, et al.
Journal of Virology|April 7, 2017
Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing AntibodiesChunhua Li, Wentao Li, Eduardo Lucio de Esesarte, et al.
Viruses|January 21, 2023
Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The NetherlandsReina S Sikkema, Erwin de Bruin, Christian Ramakers, et al.
Virulence|January 8, 2026
The essential role of heparan sulfate in the entry of PDCoV and other porcine coronavirusesNingning Ma, Mengjia Zhang, Ahmed H Ghonaim, et al.
Science Advances|May 7, 2021
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11Juliette Fedry, Daniel L Hurdiss, Chunyan Wang, et al.
One Health Outlook|June 23, 2022
Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamasJordi Rodon, Anna Z Mykytyn, Guillermo Cantero, et al.
Emerging Infectious Diseases|November 27, 2014
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997Marcel A Müller, Victor Max Corman, Joerg Jores, et al.
Pageof 12